Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Michael Martin Ollman
Introduction: Michael Martin Ollman, located in Menlo Park, California, is a prominent inventor noted for his contributions to genetic research, particularly in the area of insect tumor suppressor genes. With a keen understanding of molecular biology, Ollman's work aims to explore the nuances of p53 genetic functions.
Latest Patents: Ollman holds a significant patent concerning Insect p53 tumor suppressor genes and proteins. This patent describes a family of p53 tumor suppressor nucleic acids and proteins that have been isolated from various insect species. These discoveries have pivotal applications, including the potential for genetically modifying metazoan invertebrate organisms, such as insects and worms, or cultured cells to either express or mis-express p53. The genetically modified organisms or cells pave the way for innovative screening assays to identify candidate compounds that could act as pesticidal agents or therapeutics that influence p53 protein interactions. Furthermore, Ollman's patent encompasses the nucleic acid and protein sequences for Drosophila p33 and Rb tumor suppressors, broadening the scope of research possibilities in this essential field.
Career Highlights: Ollman is affiliated with Exelixis, Inc., a company renowned for its pioneering work in drug discovery and development. His role at Exelixis contributes to advancing biotechnological solutions that aim to address significant challenges in health and agriculture.
Collaborations: Throughout his career, Ollman has collaborated with esteemed colleagues, including Andrew Roy Buchman and Darren Platt. These partnerships foster a collaborative environment that encourages innovative thinking and the pursuit of groundbreaking scientific advancements.
Conclusion: Michael Martin Ollman's innovative work on p53 tumor suppressor genes represents an essential contribution to the field of genetic research. His patent not only underscores the potential of insect-based models in drug discovery but also positions Ollman as a key figure in the ongoing exploration of genetic mechanisms that govern cell function and disease. As research advances, the implications of Ollman's work could significantly enhance our understanding of pest control and therapeutic development.